NCT02100007 2017-10-02ME-344 Given in Combination With Hycamtin® in Patients With Solid TumorsMEI Pharma, Inc.Phase 1/2 Terminated46 enrolled 17 charts
NCT00316173 2012-11-27Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian CancerGlaxoSmithKlinePhase 2 Completed77 enrolled 14 charts